Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction
Changdong Lin, Yue Li, Yuebin Zhang, Zhaoyuan Liu, Xia Mu, Chenjian Gu, Jing Liu, Yutang Li, Guohui Li, Jianfeng Chen
Topics & Concepts
Spike ProteinIn vitroCeftazidimeDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologySars virusAntiviral drug2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Blocking (statistics)Spike (software development)PharmacologyMedicineChemistryBiologyBiochemistryBacteriaPseudomonas aeruginosaInfectious disease (medical specialty)PathologyGeneticsOutbreakManagementStatisticsMathematicsDiseaseEconomicsSARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in BacteriaBacteriophages and microbial interactions